Mohamed, Nura A.
Abou-Saleh, Haissam
Kameno, Yu
Marei, Isra
de Nucci, Gilberto
Ahmetaj-Shala, Blerina
Shala, Fisnik
Kirkby, Nicholas S.
Jennings, Lewis
Al-Ansari, Dana E.
Davies, Robert P.
Lickiss, Paul D.
Mitchell, Jane A.
Funding for this research was provided by:
British Pharmacological Society (Pickford Award-2018)
Qatar National Research Fund (PDRA3-0324-17001, PDRA4-0129-18003)
Projekt DEAL
Article History
Received: 15 April 2020
Accepted: 12 November 2020
First Online: 22 February 2021
Competing interests
: J.A.M. has received funding from Actelion Pharmaceuticals Ltd, United Therapeutics, Gesynta Pharma and in-kind donations from Merck Sharp & Dohme Corp. J.A.M. is also on the scientific advisory board for Antibe Therapeutics. Other authors declare no competing interests.